Literature DB >> 19057197

Granulocyte transfusion therapy: a new era?

David C Dale1, Thomas H Price.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19057197      PMCID： PMC2674763          DOI： 10.1097/MOH.0b013e32831d7953

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN： 1065-6251            Impact factor:   3.284


× No keyword cloud information.
  7 in total

1.  The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis.

Authors:  W I Bensinger; T H Price; D C Dale; F R Appelbaum; R Clift; K Lilleby; B Williams; R Storb; E D Thomas; C D Buckner
Journal:  Blood       Date:  1993-04-01       Impact factor: 22.113

2.  Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone.

Authors:  D C Dale; W C Liles; C Llewellyn; E Rodger; T H Price
Journal:  Transfusion       Date:  1998-08       Impact factor: 3.157

3.  Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia.

Authors:  S L Gerson; G H Talbot; S Hurwitz; B L Strom; E J Lusk; P A Cassileth
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

4.  Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.

Authors:  Nicole M Kuderer; David C Dale; Jeffrey Crawford; Leon E Cosler; Gary H Lyman
Journal:  Cancer       Date:  2006-05-15       Impact factor: 6.860

5.  A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers.

Authors:  W C Liles; J E Huang; C Llewellyn; D SenGupta; T H Price; D C Dale
Journal:  Transfusion       Date:  1997-02       Impact factor: 3.157

6.  Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors.

Authors:  Kai Hübel; Rachel A Carter; W Conrad Liles; David C Dale; Thomas H Price; Raleigh A Bowden; Scott D Rowley; Thomas R Chauncey; William I Bensinger; Michael Boeckh
Journal:  Transfusion       Date:  2002-11       Impact factor: 3.157

7.  Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans.

Authors:  T H Price; G S Chatta; D C Dale
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113
  7 in total
  6 in total

1.  Experimental evidence that granulocyte transfusions are efficacious in treatment of neutropenic hosts with pulmonary aspergillosis.

Authors:  Marife Martinez; Vicky Chen; Ann-Jay Tong; Kelsey Hamilton; Karl V Clemons; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

Review 2.  Advances in the treatment of neutropenia.

Authors:  David C Dale
Journal:  Curr Opin Support Palliat Care       Date:  2009-09       Impact factor: 2.302

3.  Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination.

Authors:  Rafael Rojas; José R Molina; Isidro Jarque; Carmen Montes; Josefina Serrano; Jaime Sanz; Juan Besalduch; Enric Carreras; José F Tomas; Luis Madero; Daniel Rubio; Eulogio Conde; Miguel A Sanz; Antonio Torres
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-02-10       Impact factor: 2.576

Review 4.  Granulocyte Colony-Stimulating Factor and Its Potential Application for Skeletal Muscle Repair and Regeneration.

Authors:  Craig R Wright; Alister C Ward; Aaron P Russell
Journal:  Mediators Inflamm       Date:  2017-12-07       Impact factor: 4.711

5.  Alternative blood products and clinical needs in transfusion medicine.

Authors:  Carolyn Whitsett; Stefania Vaglio; Giuliano Grazzini
Journal:  Stem Cells Int       Date:  2012-04-08       Impact factor: 5.443

Review 6.  Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies.

Authors:  Chiara Cugno; Sara Deola; Perla Filippini; David F Stroncek; Sergio Rutella
Journal:  J Transl Med       Date:  2015-11-16       Impact factor: 5.531
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.